-
Mashup Score: 1Vitamin D Supplementation Linked to Reduced In-Hospital, ICU Mortality in Patients With COPD - 14 hour(s) ago
Vitamin D supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (COPD), a study found.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
The FDA has approved fidanacogene elaparvovec-dzkt (Beqvez; Pfizer), a gene therapy administered in a one-time dose, for certain patients with moderate to severe hemophilia B.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1What We’re Reading: Kaiser Permanente Data Breach; GSK Sues Pfizer, BioNTech; HIV Infections via Cosmetic Injections - 19 hour(s) ago
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0Melatonin Fails to Ease Fatigue in Patients With Early-Stage Breast Cancer Undergoing Radiotherapy - 2 day(s) ago
Melatonin showed no benefit for cancer-related fatigue or other symptoms in women with early-stage breast cancer receiving radiotherapy treatment.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Dr Ryan Stice Shares Strategy on Expanding Access to Care With Virtual Population Health Teams - 2 day(s) ago
In an interview during The American Journal of Managed Care®’s Institute for Value-Based Medicine® event, held with Sutter Health, Ryan Stice, PharmD, BCPS, explains the impact virtual population health teams can have on improving access to care for patients with cardiometabolic conditions.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0Talquetamab Cost-Effective Breakthrough for RRMM - 2 day(s) ago
The FDA granted accelerated approval to talquetamab on August 9, 2023, as a treatment option for adult patients with relapsed/refractory multiple myeloma (RRMM) who have failed at least 4 prior lines of therapy.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Optimizing BTK Inhibitors in CLL and SLL - 3 day(s) ago
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Source: www.ajmc.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 0What We’re Reading: FTC Noncompete Ban Finalized; Unchecked Hospital Mergers Raised Health Costs; H5N1 Bird Flu Virus Particles Found - 3 day(s) ago
The Federal Trade Commission’s (FTC’s) vote to ban most employers from issuing and enforcing noncompete clauses could have varying impacts on the health care workforce; federal regulators vastly under-enforced antitrust laws in the hospital sector during the last 2 decades, resulting in increased health costs; the FDA recently found genetic evidence of the H5N1 bird flu virus in pasteurized commercially purchased milk.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1Dr Robert Zimmerman Discusses Challenges, Adverse Effects of GLP-1 and Multi-Agonist Therapies - 3 day(s) ago
Robert Zimmerman, MD, discussed the adverse side effects associated with glucagon-like peptide-1 (GLP1) and multi-agonist therapies, as well as explored the challenges in developing these interventions.
Source: www.ajmc.comCategories: General Medicine News, PayerTweet-
Dr Robert Zimmerman of @ClevelandClinic recently discussed with #AJMC the adverse side effects associated with glucagon-like peptide-1 ( #GLP1 ) and multi-agonist therapies; he also explored the challenges in developing these interventions. Watch here: https://t.co/FaHfqV2gFS https://t.co/a3kaoZrIHQ
-
-
Mashup Score: 0Award-Winning Poster Presentations From AMCP 2024 - 4 day(s) ago
At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
#VitaminD supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (#COPD), a study found. Read more: https://t.co/iigaNWGtIf